Related Experiment Video

Updated: Dec 13, 2025

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
03:19

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes

Published on: June 28, 2024

662

Maternal obesity: focus on offspring cardiometabolic outcomes

Alessandra Gambineri1, Alessandro Conforti2, Andrea Di Nisio3

  • 1Endocrinology Unit, Department of Medical and Surgical Sciences, St Orsola-Malpighi Hospital, Alma Mater University of Bologna, Bologna, Italy.

International Journal of Obesity Supplements
|July 28, 2020
PubMed

Insights

Maternal obesity before and during pregnancy negatively impacts offspring cardiometabolic health. This review highlights the link between maternal weight excess and offspring metabolic and cardiovascular disorders.

Area of Science:

  • Cardiology
  • Metabolic Health
  • Pediatrics

Background:

  • Cardiometabolic parameters are influenced by factors beyond energy imbalance.
  • Maternal weight excess is a significant determinant of offspring health.
  • Prenatal and postnatal development are critical periods for cardiometabolic programming.

Purpose of the Study:

  • To review the impact of maternal obesity on offspring cardiometabolic health.
  • To synthesize evidence from human and animal studies.
  • To highlight the association between maternal weight excess and offspring cardiometabolic disorders.

Main Methods:

  • Comprehensive literature review of human and animal studies.
  • Analysis of data on cardiometabolic parameters in offspring.
  • Focus on maternal pre-pregnancy and pregnancy weight status.

Main Results:

  • Maternal obesity is linked to adverse cardiometabolic outcomes in offspring across developmental stages.
  • Evidence suggests a causal relationship between maternal weight excess and offspring metabolic dysfunction.
  • Cardiovascular health in offspring is demonstrably affected by maternal weight status.

Conclusions:

  • Maternal obesity poses a significant risk for developing cardiometabolic disorders in offspring.
  • Interventions targeting maternal weight management are crucial for preventing long-term health issues in children.
  • Further research is warranted to elucidate specific mechanisms and develop targeted preventative strategies.

More Related Videos

Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy05:17

Author Spotlight: Enhancing the Offspring Health in Rats with Maternal Exercise During Pregnancy

Published on: April 5, 2024

1.1K
A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta11:44

A Primary Human Trophoblast Model to Study the Effect of Inflammation Associated with Maternal Obesity on Regulation of Autophagy in the Placenta

Published on: September 27, 2017

11.7K

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
103
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
530
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
145